Outcomes by primary tumour location in patients with advanced biliary tract cancer treated with durvalumab or placebo plus gemcitabine and cisplatin in the phase 3 TOPAZ-1 study
Authors
He, A.Valle, Juan W
Lee, C.
Ikeda, M.
Potemski, P.
Morizane, C.
Cundom, J.
Tougeron, D.
Dayyani, F.
Rokutanda, N.
Xiong, J.
Cohen, G.
Oh, D.
Affiliation
Lombardi Comprehensive Cancer Center, Georgetown University, WashingtonIssue Date
2022